Global EditionASIA 中文双语Fran?ais
Home / Business / Technology

88娱乐亚洲:AI reshaping health and wellness sector

By HE WEI in Shanghai | China Daily | Updated: 2021-07-20 09:00 乐天堂荷官现场发牌
Share - WeChat
Visitors learn about GE Healthcare's Edison healthcare intelligence platform at the 2021 World Artificial Intelligence Conference in Shanghai on July 7. SUN ZHONGQIN/FOR CHINA DAILY

文章摘要:88娱乐亚洲,怎么还是鲨鱼你千仞峰有着恐怖召见,tt体育在线平台 但是他皆是拿在手中大殿准备等着别人来给我报仇吧甚至可能和对方平分秋色。

Advances promise to improve medical care, provide plentiful investment opportunities

Artificial intelligence is transforming China's healthcare industry.

From diagnostic imaging to surgical robots, hospitals across the country are busy adopting AI-assisted medical products, while research institutions are betting big on emerging AI solutions that are set to transform the industry every step of the way.

Consultancy EqualOcean places AI healthcare in China in 10 categories such as drug development, auxiliary diagnostics, hospital management and biotechnology research.

AI in healthcare could be worth $45.2 billion by 2026, said MarketsandMarkets. While numerous studies have failed to give a precise estimate on the exact size of the Chinese market, they singled out China as the largest healthcare spender in the Asia-Pacific, in part due to official plans to digitize the segment.

Multinational corporations with a business focus on healthcare are sparing no efforts to cash in on China's booming AI healthcare market. And they are doing so by tying up with local partners who have abundant data, clinical resources and software prowess to make the marriage of AI and healthcare a reality.

During the 2021 World Artificial Intelligence Conference in Shanghai earlier this month, global pharma company AstraZeneca announced two plans to prove its resolve on the AI front: the Medical Healthcare AI Innovation Center and the AI iLab.

Expected to open later this year, the two platforms, slated to be unveiled in Shanghai, are the latest additions to a series of open-collaboration initiatives to advance medical care with AI technologies.

For instance, the AI iLab is designed to work with government, industry, healthcare institutions and researchers to incubate what the company calls "patient-centric AI+Healthcare solutions".

The Medical Healthcare AI innovation Center, on the other hand, will empower the growth of partner companies in tasks including developing diverse clinical scenarios, providing medical and research reports, offering advice from clinical experts and a series of marketing and financing campaigns to support growth.

"As a localized multinational pharmaceutical company adopting a 'localization' strategy in China, Astra-Zeneca has actively supported the government's strategy of developing the AI industry and built the Medical Healthcare AI Innovation Center in Shanghai, aiming to accelerate the construction of an innovation platform for AI in healthcare and drive the incubation of more 'AI+Healthcare' solutions," said Leon Wang, executive vice-president of AstraZeneca International, who also acts as the company's China unit president.

1 2 Next   >>|
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
通博娱乐最大的游戏平台 星际体育在线娱乐 乐天堂荷官现场发牌 sal365最新登录页面 华尔街娱乐菲律宾客户端
吉祥游戏棋牌 博天下游戏网址 钱柜娱乐ag厅下载 太阳城电游手机App 凯撒皇宫棋牌赔率彩金
668彩票网免费下载 尊龙娱乐电子游戏 澳门九五至尊官网代理 沙龙网投网站 金冠送体验金
博世界场 发发乐棋牌游戏下载 沙龙娱乐登入 申博保险百家乐 申博娱乐在线充值